secwatch / observer
8-K filed May 4, 2022, 7:59 PM ET ticker AXON CIK 0001069183
leadership confidence high sentiment positive materiality 0.70

Axon CFO resigns, Jim Zito interim; raises 2022 rev outlook to $1.05-1.1B

AXON ENTERPRISE, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jawad A. Ahsan

Chief Financial Officer
AXON · AXON ENTERPRISE, INC.
Effective
2022-05-04
Successor
Jim Zito
Filed
May 4, 2022, 7:59 PM ET
On May 4, 2022, Axon Enterprise, Inc. (the “Company”) announced that Jawad A. Ahsan would be resigning as Chief Financial Officer (“CFO”), effective immediately, to pursue other opportunities.
Appointed (interim)

Jim Zito

Interim Chief Financial Officer
AXON · AXON ENTERPRISE, INC.
Effective
2022-05-04
Filed
May 4, 2022, 7:59 PM ET
As of the same date, the Company appointed Jim Zito as interim CFO, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jawad A. Ahsan departed as Chief Financial Officer at AXON ENTERPRISE, INC..

Action
resigning
Role
Chief Financial Officer
Exact text from the filing
On May 4, 2022, Axon Enterprise, Inc. (the “Company”) announced that Jawad A. Ahsan would be resigning as Chief Financial Officer (“CFO”), effective immediately, to pursue other opportunities.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jim Zito was appointed as Interim Chief Financial Officer at AXON ENTERPRISE, INC..

Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
As of the same date, the Company appointed Jim Zito as interim CFO, effective immediately.
View on SEC.gov

AXON ENTERPRISE, INC. filing history →

Source: SEC EDGAR
accession 0001069183-22-000010
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.